Evaluating the Barrier Function, Regenerative Capacity, and Soft Tissue Outcomes of Acellular Dermal Matrix

ConditionsAcellular Dermal Matrix Bone Grafting Soft Tissue Grafting

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-85

SponsorUniversity of Alabama at Birmingham

About this trial

This investigator-initiated study will compare ADM and resorbable cross-linked collagen membrane barriers for guided bone regeneration at atrophic lateral ridge augmentation sites.

Eligibility criteria

Qualifiers

English speaking

At least 18 years old

Must be a patient of the UAB Dental School

Able to read and understand informed consent document

Disqualifiers

Non-English speaking

Less than 18 years old

Smokers/nicotine users (defined as currently reporting use of any form of tobacco/nicotine products)

Uncontrolled diabetes (HbA1c > 7%)

Trial design

Treatments tested in this trial

Guided Bone Regeneration with ADM (AlloDerm) as a barrier
Guided Bone Regeneration with Resorbable Crosslinked Collagen Matrix (Mem-Lok) as a barrier

Treatment groups

70 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

Source ClinicalTrials.gov